Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan.

Cancer genomics & proteomics - 1 Jan 2000

Aoyama Rika, Nishikubo Hinano, Kawabata Kyoka, Kanei Saki, Yamamoto Yurie, Nishimura Sadaaki, Yashiro Masakazu

Abstract excerpt

BACKGROUND/AIM: Multi-cancer genome profiling (multi-CGP) testing intends to predict the therapeutic efficacy of anticancer medication treatments for eligible patients as part of "precision cancer care." The number of cases in which a new treatment was applied based on multi-CGP testing has been reported to be between 10% and 20% for all patients in Japan. This study aimed to determine the significance of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hospitals
Share to Japan
Share to Clinical Relevance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38151295
DOI: 10.21873/cgp.20431
PMCID: PMC10756342

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan.PMID 38151295Read ↗

Clinical Significance of Multi-Cancer Genome Profiling: Data from A Japan HospitalSemantic proximity Read ↗

Clinical and diagnostic utility of genomic profiling for digestive cancers: real-world evidence from JapanSemantic proximity Read ↗

Clinical Utility of Comprehensive Genomic Profiling Tests Using MTB Management System at a Single Center in JapanSemantic proximity Read ↗

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.Semantic proximity Read ↗

A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study).Semantic proximity Read ↗

Incorporating tumor genomic profiling and drug screening through circulating tumor cell- derived organoids into clinical practice for the management of Gastrointestinal CancersSemantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity Read ↗

Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in JapanSemantic proximity Read ↗

[Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)].Semantic proximity Read ↗

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.Semantic proximity Read ↗

Technological advances in clinical individualized medication for cancer therapy: from genes to whole organismSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.